Lundbeck Seattle BioPharmaceuticals, Inc design mark 99371530
"Design mark 99371530" is a figurative mark owned by Lundbeck Seattle BioPharmaceuticals, Inc., filed at the USPTO on September 3, 2025. It has been allowed and covers classes 9, 38, 41, 42 and 45.
- Status
- Allowed
- Since October 20, 2026
- Filed
- September 3, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99371530
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 5 classes
Who owns Lundbeck Seattle BioPharmaceuticals, Inc design mark 99371530
The owner and representative on file with the office.
Owner
Lundbeck Seattle BioPharmaceuticals, Inc.
Bothell, United States
Representative
Maren Perry
King & Spalding LLP
What the mark covers
The products and services Lundbeck Seattle BioPharmaceuticals, Inc design mark 99371530 is filed for, grouped by Nice class.
Software for providing healthcare and patient support services, namely, downloadable software application for monitoring and tracking information for migraine management purposes, for prescription medication management and management of a patient’s health and wellness with respect to migraines, and for providing access for patients to inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community
Provision of online forums, chat rooms, and electronic bulletin boards for users to post, search, view, share, criticize, rate, and comment on topics of interest; Providing access to computer, electronic and online databases; Transmission of audio, text, video and multimedia via computer and electronic communications networks, namely, the uploading, posting, displaying, tagging and electronic transmission of data, audio and video
Providing online non-downloadable electronic publications in the nature of books, reports, brochures, booklets, magazines, leaflets, journals, teaching and training materials in the fields of medicines, pharmaceuticals, disorders, diseases, treatment and prevention
Development of software applications for computers and mobile devices in the medical and healthcare fields; Computer services, namely, creating an on-line community for registered users to participate in discussions, get feedback from their peers, form virtual communities, upload, exchange and share photos, videos and audio files, and engage in social networking services in the field of healthcare
Online social networking services provided through a healthcare community website
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Examiner's amendment entered
8 earlier steps on the official record.
About Lundbeck Seattle BioPharmaceuticals, Inc design mark 99371530
Who owns the trademark "Design mark 99371530"?
The USPTO trademark "Design mark 99371530" (application 99371530) is owned by Lundbeck Seattle BioPharmaceuticals, Inc.
What is the status of "Design mark 99371530"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull Lundbeck Seattle BioPharmaceuticals, Inc design mark 99371530 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b20-e875-72bc-b273-4159959b9785
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b20-e875-72bc-b273-4159959b9785",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99371530",
"filing_date": "2025-09-03",
"nice_classes": [
9,
38,
41,
42,
45
],
"owners": [
{
"name": "Lundbeck Seattle BioPharmaceuticals, Inc.",
"entity_id": null
}
]
}